API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
64
PharmaCompass offers a list of Dihydroartemisinin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dihydroartemisinin manufacturer or Dihydroartemisinin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dihydroartemisinin manufacturer or Dihydroartemisinin supplier.
PharmaCompass also assists you with knowing the Dihydroartemisinin API Price utilized in the formulation of products. Dihydroartemisinin API Price is not always fixed or binding as the Dihydroartemisinin Price is obtained through a variety of data sources. The Dihydroartemisinin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dihydroartemisinin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydroartemisinin, including repackagers and relabelers. The FDA regulates Dihydroartemisinin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydroartemisinin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihydroartemisinin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihydroartemisinin supplier is an individual or a company that provides Dihydroartemisinin active pharmaceutical ingredient (API) or Dihydroartemisinin finished formulations upon request. The Dihydroartemisinin suppliers may include Dihydroartemisinin API manufacturers, exporters, distributors and traders.
click here to find a list of Dihydroartemisinin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dihydroartemisinin written confirmation (Dihydroartemisinin WC) is an official document issued by a regulatory agency to a Dihydroartemisinin manufacturer, verifying that the manufacturing facility of a Dihydroartemisinin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dihydroartemisinin APIs or Dihydroartemisinin finished pharmaceutical products to another nation, regulatory agencies frequently require a Dihydroartemisinin WC (written confirmation) as part of the regulatory process.
click here to find a list of Dihydroartemisinin suppliers with Written Confirmation (WC) on PharmaCompass.
Dihydroartemisinin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dihydroartemisinin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihydroartemisinin GMP manufacturer or Dihydroartemisinin GMP API supplier for your needs.
A Dihydroartemisinin CoA (Certificate of Analysis) is a formal document that attests to Dihydroartemisinin's compliance with Dihydroartemisinin specifications and serves as a tool for batch-level quality control.
Dihydroartemisinin CoA mostly includes findings from lab analyses of a specific batch. For each Dihydroartemisinin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dihydroartemisinin may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihydroartemisinin EP), Dihydroartemisinin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihydroartemisinin USP).